Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience

Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more acc...

Full description

Saved in:
Bibliographic Details
Published in:JAC-antimicrobial resistance 2024-10, Vol.6 (5), p.dlae155
Main Authors: Skogen, Vegard, Helleren, Rita, Jacobsen, Marianne Giske, Opsal, Anne, Gallefoss, Frode
Format: Article
Language:English
Subjects:
Original
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c334t-983869bf77ad818253575852632eba906793d41d150e83915812dd2bf60af0a53
container_end_page
container_issue 5
container_start_page dlae155
container_title JAC-antimicrobial resistance
container_volume 6
creator Skogen, Vegard
Helleren, Rita
Jacobsen, Marianne Giske
Opsal, Anne
Gallefoss, Frode
description Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.
doi_str_mv 10.1093/jacamr/dlae155
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11472154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jacamr/dlae155</oup_id><sourcerecordid>3116676744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-983869bf77ad818253575852632eba906793d41d150e83915812dd2bf60af0a53</originalsourceid><addsrcrecordid>eNqFUj1v2zAQFYoWTZBm7dhytAcnpCiKUpfCcPoFBHWHdCZO0slmQIkqSdnxn-tvK1U7QTp1uq937w4PL0neMnrFaMmv76GGzl03BpAJ8SI5T3OeLliR8pfP8rPk0vt7SmkqqMxk-jo542VGeS7FefJ7PYYBgsY-kAFcDOjAEOiD7nTtbKVjFbaxORzIbP1jeTcno9f9hgCpbUT1ox09ga4aDQTrDqRBo3f4N9npGslstby5mRMwxu6nveAQQjfd2-uwJd1ogh4Mkga0iUvWo_8QySunsSUOB-sCsW3sfLdujxsNPcGHAeO4r_FN8qoF4_HyFC-Sn58_3a2-Lm7XX76tlreLmvMsLMqCF3lZtVJCU0RNBBdSFGKSCCsoaS5L3mSsYYJiwUsmCpY2TVq1OYWWguAXyccj7zBWHTZ1fD_KpAanO3AHZUGrfye93qqN3SnGouJMZJHh_ZGhdtpH2VRvHShGKZeKi1wUETE73XD214g-qE77Go2BHqPGijOW5zKX2UR29UhmvXfYPn3CqJqsoY7WUCdrxIV3z_9_gj8aIQLmR4Adh_-R_QFrdMen</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116676744</pqid></control><display><type>article</type><title>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</title><source>Open Access: PubMed Central</source><source>NORA - Norwegian Open Research Archives</source><source>Oxford University Press Open Access</source><creator>Skogen, Vegard ; Helleren, Rita ; Jacobsen, Marianne Giske ; Opsal, Anne ; Gallefoss, Frode</creator><creatorcontrib>Skogen, Vegard ; Helleren, Rita ; Jacobsen, Marianne Giske ; Opsal, Anne ; Gallefoss, Frode</creatorcontrib><description>Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.</description><identifier>ISSN: 2632-1823</identifier><identifier>EISSN: 2632-1823</identifier><identifier>DOI: 10.1093/jacamr/dlae155</identifier><identifier>PMID: 39403675</identifier><language>eng</language><publisher>UK: Oxford University Press</publisher><subject>Original</subject><ispartof>JAC-antimicrobial resistance, 2024-10, Vol.6 (5), p.dlae155</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.</rights><rights>info:eu-repo/semantics/openAccess</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c334t-983869bf77ad818253575852632eba906793d41d150e83915812dd2bf60af0a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472154/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472154/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1598,26544,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39403675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Skogen, Vegard</creatorcontrib><creatorcontrib>Helleren, Rita</creatorcontrib><creatorcontrib>Jacobsen, Marianne Giske</creatorcontrib><creatorcontrib>Opsal, Anne</creatorcontrib><creatorcontrib>Gallefoss, Frode</creatorcontrib><title>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</title><title>JAC-antimicrobial resistance</title><addtitle>JAC Antimicrob Resist</addtitle><description>Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.</description><subject>Original</subject><issn>2632-1823</issn><issn>2632-1823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>3HK</sourceid><recordid>eNqFUj1v2zAQFYoWTZBm7dhytAcnpCiKUpfCcPoFBHWHdCZO0slmQIkqSdnxn-tvK1U7QTp1uq937w4PL0neMnrFaMmv76GGzl03BpAJ8SI5T3OeLliR8pfP8rPk0vt7SmkqqMxk-jo542VGeS7FefJ7PYYBgsY-kAFcDOjAEOiD7nTtbKVjFbaxORzIbP1jeTcno9f9hgCpbUT1ox09ga4aDQTrDqRBo3f4N9npGslstby5mRMwxu6nveAQQjfd2-uwJd1ogh4Mkga0iUvWo_8QySunsSUOB-sCsW3sfLdujxsNPcGHAeO4r_FN8qoF4_HyFC-Sn58_3a2-Lm7XX76tlreLmvMsLMqCF3lZtVJCU0RNBBdSFGKSCCsoaS5L3mSsYYJiwUsmCpY2TVq1OYWWguAXyccj7zBWHTZ1fD_KpAanO3AHZUGrfye93qqN3SnGouJMZJHh_ZGhdtpH2VRvHShGKZeKi1wUETE73XD214g-qE77Go2BHqPGijOW5zKX2UR29UhmvXfYPn3CqJqsoY7WUCdrxIV3z_9_gj8aIQLmR4Adh_-R_QFrdMen</recordid><startdate>20241014</startdate><enddate>20241014</enddate><creator>Skogen, Vegard</creator><creator>Helleren, Rita</creator><creator>Jacobsen, Marianne Giske</creator><creator>Opsal, Anne</creator><creator>Gallefoss, Frode</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>3HK</scope><scope>5PM</scope></search><sort><creationdate>20241014</creationdate><title>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</title><author>Skogen, Vegard ; Helleren, Rita ; Jacobsen, Marianne Giske ; Opsal, Anne ; Gallefoss, Frode</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-983869bf77ad818253575852632eba906793d41d150e83915812dd2bf60af0a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Skogen, Vegard</creatorcontrib><creatorcontrib>Helleren, Rita</creatorcontrib><creatorcontrib>Jacobsen, Marianne Giske</creatorcontrib><creatorcontrib>Opsal, Anne</creatorcontrib><creatorcontrib>Gallefoss, Frode</creatorcontrib><collection>Oxford University Press Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>NORA - Norwegian Open Research Archives</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAC-antimicrobial resistance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Skogen, Vegard</au><au>Helleren, Rita</au><au>Jacobsen, Marianne Giske</au><au>Opsal, Anne</au><au>Gallefoss, Frode</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience</atitle><jtitle>JAC-antimicrobial resistance</jtitle><addtitle>JAC Antimicrob Resist</addtitle><date>2024-10-14</date><risdate>2024</risdate><volume>6</volume><issue>5</issue><spage>dlae155</spage><pages>dlae155-</pages><issn>2632-1823</issn><eissn>2632-1823</eissn><abstract>Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) is safe, effective and increasingly available. While OPAT in Norwegian healthcare has been rare, a new continuous ambulatory delivery device (CADD) allowing multiple daily dosing treatments has been innovated making OPAT more accessible. Objectives To describe the clinical outcome and safety using CADD in an OPAT setting. Methods Adult patients in need of parenteral antibiotic treatment were offered OPAT and discharged with a programmable digital infusion pump allowing multiple daily dosings. Results Altogether, 170 patients were included in the study, among which 21% of all patients (36 of 170) were readmitted to hospital while receiving OPAT or within 30 days after end of intravenous antibiotics. None of the 170 patients died due to OPAT and allergies were not noticeable as a problem. Conclusions We have developed a safe and clinically effective programme offering OPAT in accordance with Norwegian antibiotic treatment guidelines.</abstract><cop>UK</cop><pub>Oxford University Press</pub><pmid>39403675</pmid><doi>10.1093/jacamr/dlae155</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2632-1823
ispartof JAC-antimicrobial resistance, 2024-10, Vol.6 (5), p.dlae155
issn 2632-1823
2632-1823
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11472154
source Open Access: PubMed Central; NORA - Norwegian Open Research Archives; Oxford University Press Open Access
subjects Original
title Outpatient parenteral antimicrobial therapy (OPAT) using a continuous ambulatory delivery device (CADD) allowing treatment with multiple daily doses: a brief report of a Norwegian experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A12%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outpatient%20parenteral%20antimicrobial%20therapy%20(OPAT)%20using%20a%20continuous%20ambulatory%20delivery%20device%20(CADD)%20allowing%20treatment%20with%20multiple%20daily%20doses:%20a%20brief%20report%20of%20a%20Norwegian%20experience&rft.jtitle=JAC-antimicrobial%20resistance&rft.au=Skogen,%20Vegard&rft.date=2024-10-14&rft.volume=6&rft.issue=5&rft.spage=dlae155&rft.pages=dlae155-&rft.issn=2632-1823&rft.eissn=2632-1823&rft_id=info:doi/10.1093/jacamr/dlae155&rft_dat=%3Cproquest_pubme%3E3116676744%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c334t-983869bf77ad818253575852632eba906793d41d150e83915812dd2bf60af0a53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3116676744&rft_id=info:pmid/39403675&rft_oup_id=10.1093/jacamr/dlae155&rfr_iscdi=true